Live tape
Top 8, mentions 7d7,637NVDA1,345 mentions▲ +0.09GOOGL1,166 mentions▲ +0.04AVGO1,034 mentions▲ +0.05NKE1,030 mentions+0.01LULU964 mentions▲ +0.03TSLA923 mentions▲ +0.06META634 mentions▲ +0.05QQQ541 mentions▲ +0.08

Equity · Healthcare

BLTE

Belite Bio, Inc · NasdaqCM

$194 +13.45% 1D Finazon · prior-day close · Sep 4, 2026
Price · Chart
Our own end-of-day closes 61 sessions
$200 $120 10 Jun 4 Sep

The line runs $137 on 10 June through $194 on 4 September, on a scale from $120 to $200. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of BLTE over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 61 sessions over that window: $137 on 10 June 2026 through $194 on 4 September 2026.

52-week range $63.29 – $194
Avg volume 22.5K

Finazon · prior-day close · as of Sep 8, 2026

Filings 3 sets

BLTE reported financials

SEC EDGAR XBRL

BLTE reported net income of −$77.6M for the fiscal year ended 31 Dec 2025.

Figure Reported Period
Net income −$77.6M 31 Dec 2025 fiscal year
Diluted EPS −$2.31 31 Dec 2025 fiscal year
Total assets $780.6M 31 Dec 2025 at period end
Total equity $770.5M 31 Dec 2025 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Dec 2025

BLTE institutional holders

SEC Form 13F

7 of the 45 institutional funds we track reported a BLTE position for the quarter ended 30 Jun 2026 — a combined $204.5M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Millennium Management Held (±25%) −13.2% shares 494,564 $76.2M
Maverick Capital New position 396,311 $61.0M
Citadel Advisors Added +9,171.3% shares 186,168 $28.7M
Duquesne Family Office Held (±25%) 106,100 $16.3M
Renaissance Technologies Held (±25%) +7.2% shares 55,763 $8.6M
Point72 Asset Management New position 51,186 $7.9M
Two Sigma Investments New position 38,100 $5.9M
Tudor Investment Corp Exited

Source: SEC EDGAR 13F filings

BLTE fails-to-deliver

SEC CNS data

On 05 Aug 2026, 51 shares of BLTE failed to deliver (about $8K).

Settlement date Shares failed Notional % of shares out
05 Aug 2026 51 $8K <0.001%
31 Jul 2026 27 $4K <0.001%
29 Jul 2026 48 $7K <0.001%
27 Jul 2026 1,303 $200K 0.003%

Source: SEC fails-to-deliver (CNS) data